Evexia Lifecare Ltd Falls to 52-Week Low of Rs.0.75 Amid Continued Downtrend

Stock Performance and Market Context

On 20 Mar 2026, Evexia Lifecare’s share price declined by 9.09% in a single trading session, underperforming the edible oil sector by 3.02%. This marks the sixth consecutive day of losses, during which the stock has delivered a cumulative negative return of 48.28%. The current price of Rs.0.75 is substantially lower than its 52-week high of Rs.3.04, representing a steep depreciation over the past year.

The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish trend. Technical indicators reinforce this outlook, with the MACD showing bearish signals on both weekly and monthly charts, Bollinger Bands indicating downward momentum, and the KST and Dow Theory assessments mildly bearish across weekly and monthly timeframes. The Relative Strength Index (RSI) on a weekly basis shows some bullishness, but this has not translated into price recovery.

Financial Metrics and Fundamental Analysis

Evexia Lifecare’s financial fundamentals have been under strain, contributing to the stock’s weak performance. The company has experienced a negative compound annual growth rate (CAGR) of -23.63% in operating profits over the last five years. Profitability metrics remain subdued, with an average Return on Equity (ROE) of just 0.88%, indicating limited returns generated on shareholders’ funds.

Debt servicing capacity is a concern, as reflected by a Debt to EBITDA ratio of -1.00 times, suggesting challenges in managing leverage effectively. Despite these pressures, the company maintains an attractive valuation profile, with a Return on Capital Employed (ROCE) of 0.1 and an Enterprise Value to Capital Employed ratio of 0.8, indicating that the stock is trading at a discount relative to its capital base and peer valuations.

Profitability has also declined sharply, with profits falling by 60.3% over the past year. This decline has outpaced the stock’s negative return of 74.45% during the same period, underscoring the financial difficulties faced by the company.

Shareholding and Market Capitalisation

Evexia Lifecare is classified as a micro-cap stock, with majority shareholding held by non-institutional investors. This ownership structure may influence liquidity and trading dynamics. The company operates within the edible oil industry, a sector that has seen mixed performance relative to broader market indices.

Comparatively, the Sensex has shown resilience, rising 1.06% on the same day to close at 74,991.79, despite trading below its 50-day moving average and remaining 4.76% above its own 52-week low of 71,425.01. Mega-cap stocks have led the market rally, contrasting with the subdued performance of smaller companies like Evexia Lifecare.

Recent Financial Results

The company reported flat results in the quarter ending December 2025, which did not provide a catalyst for price improvement. The lack of significant earnings growth or margin expansion has contributed to the cautious market sentiment surrounding the stock.

Technical Summary and Market Sentiment

Technical analysis continues to reflect a bearish outlook for Evexia Lifecare. The stock’s daily moving averages are all trending downward, and weekly indicators such as MACD, Bollinger Bands, and KST remain bearish. The Dow Theory assessment is mildly bearish on both weekly and monthly timeframes, suggesting that the stock is still in a downtrend phase.

Despite a weekly RSI showing some bullish tendencies, this has not been sufficient to reverse the prevailing negative momentum. The stock’s consistent underperformance relative to its sector and the broader market highlights ongoing challenges in regaining investor confidence.

Valuation and Comparative Positioning

Evexia Lifecare’s valuation metrics indicate that it is trading at a discount compared to its peers’ historical averages. The Enterprise Value to Capital Employed ratio of 0.8 suggests that the market values the company below the capital it employs, which may reflect concerns about future earnings potential and capital efficiency.

While the Return on Capital Employed (ROCE) is modest at 0.1, this figure is not sufficient to offset the broader concerns regarding profitability and growth. The company’s subdued financial performance over the past year, including a 60.3% decline in profits, has weighed heavily on its market valuation.

Summary of Key Metrics

To summarise, Evexia Lifecare Ltd’s key financial and market metrics as of 20 Mar 2026 are:

• New 52-week low price: Rs.0.75
• One-year stock return: -74.45%
• One-year profit decline: -60.3%
• Operating profit CAGR (5 years): -23.63%
• Debt to EBITDA ratio: -1.00 times
• Average Return on Equity: 0.88%
• Return on Capital Employed: 0.1
• Enterprise Value to Capital Employed: 0.8
• Mojo Score: 23.0 (Strong Sell, upgraded from Sell on 28 Apr 2025)
• Market Capitalisation: Micro-cap

These figures collectively illustrate the pressures faced by the company in maintaining profitability and market valuation within a competitive edible oil sector.

Conclusion

Evexia Lifecare Ltd’s fall to a new 52-week low of Rs.0.75 reflects a continuation of a challenging period marked by declining profits, subdued returns, and technical weakness. The stock’s performance contrasts with broader market gains, particularly among mega-cap stocks, and highlights the difficulties faced by smaller companies in the current market environment. While valuation metrics suggest the stock is trading at a discount, the prevailing financial and technical indicators underscore the ongoing pressures on the company’s market standing.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →